Q3 2022 · 13F-HR
Antipodean Advisors LLCholdings as filed
Filed 2022-11-14 · accession 0000919574-22-006610
$39,080
Reported value
7
Positions
2022-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 81141R100 | SE | SEA LTD | $19,618 | 50.2% | 350,000 | Common | SOLE |
| 146869102 | CVNA | CARVANA CO | $7,207 | 18.4% | 355,000 | Common | SOLE |
| 14161W105 | CDLX | CARDLYTICS INC | $5,080 | 13.0% | 540,400 | Common | SOLE |
| 046513107 | ATRAGBX | ATARA BIOTHERAPEUTICS INC | $3,780 | 9.67% | 1,000,000 | Common | SOLE |
| 14171W103 | — | CAREMAX INC | $3,013 | 7.71% | 425,000 | Common | SOLE |
| 92189F106 | GDX | VANECK ETF TRUST | $241 | 0.62% | 10,000 | Common | SOLE |
| 92189F403 | — | VANECK ETF TRUST | $141 | 0.36% | 25,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.